Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pascolizumab in symptomatic steroid-naive asthma
NCT00024544Phase 2Completed
- Sponsor
- Facet Biotech Corporation
- Start
- Aug 2001
- Primary completion
- Feb 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pascolizumab in asthma, sponsored by Facet Biotech Corporation. Started Aug 2001; status: completed.
02
Drugs
pascolizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00024544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024544.